NCT06274788 2025-09-05Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentFresenius KabiRecruiting40 enrolled
NCT04807478 2022-08-04Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)Fresenius KabiWithdrawn